Senior insider sale
Chief Business Officer at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$600.0K
40K shares
What this filing means
KREMPA DAVID plans to sell 40K shares of ETON PHARMACEUTICALS, INC. valued at approximately $600.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/12/2025ACC: 0001974078-25-000181
Officer· Chief Business Officer
Since Mar 2023
40K
Shares to sell
$600.0K
Approx. market value
45.66K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months9
Grant
Grant
7/12/2024
10KESPP
Payroll
6/10/2024
5.86KESPP
Payroll
12/10/2023
2.16KGrant
Grant
7/12/2023
10KESPP
Payroll
6/9/2023
5.81KESPP
Payroll
12/9/2022
2.28KESPP
Payroll
6/10/2022
4.64KESPP
Payroll
12/10/2021
1.20KESPP
Payroll
6/10/2021
3.70KTotal acquired45.66K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/12/2024 | Grant Grant | 10K | — |
6/10/2024 | ESPP Payroll | 5.86K | — |
12/10/2023 | ESPP Payroll | 2.16K | — |
7/12/2023 | Grant Grant | 10K | — |
6/9/2023 | ESPP Payroll | 5.81K | — |
12/9/2022 | ESPP Payroll | 2.28K | — |
6/10/2022 | ESPP Payroll | 4.64K | — |
12/10/2021 | ESPP Payroll | 1.20K | — |
6/10/2021 | ESPP Payroll | 3.70K | — |
| Total | 45.66K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
40K
Market value
$600.0K
6/12/2025
Total
Units
40K
Value
$600.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/12/2025 | 40K | $600.0K | NASDAQ | Planned |
| Total | 40K | $600.0K | ||